Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Britschgi

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|March 17, 2009
Tumor suppressor genes in myeloid differentiation and leukemogenesisChristian Britschgi, Martin F Fey
Swiss Medical Weekly|November 25, 2010
Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation?Mathias Jenal, Christian Britschgi, Martin F Fey, et al.
Radiation Oncology (London, England)|June 2, 2018
Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancerChristian Britschgi, Oliver Riesterer, Irene A Burger, et al.
Oncotarget|April 23, 2016
Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1Kamil Andrzej Lipinski, Christian Britschgi, Karen Schrader, et al.
Molecular Genetics & Genomic Medicine|August 5, 2020
Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene)Reza Asadollahi, Christian Britschgi, Pascal Joset, et al.
International Journal of Molecular Sciences|February 13, 2026
Identification of DMP1 as Novel p53 Repressed Transcriptional TargetJun Xu, Christian Britschgi, Gustav Arvidsson, et al.
JCO Clinical Cancer Informatics|August 25, 2022
MTPpilot: An Interactive Software for Visualization of Next-Generation Sequencing Results in Molecular Tumor BoardsAbdullah Kahraman, Fabian M Arnold, Jacob Hanimann, et al.
Scientific Reports|May 25, 2019
BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assemblyLukas Frischknecht, Christian Britschgi, Patricia Galliker, et al.
Targeted Oncology|September 22, 2022
Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET geneAlessa Fischer, Lorenz Bankel, Stefanie Hiltbrunner, et al.
JCO Precision Oncology|January 7, 2022
Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal CancerDilara Akhoundova, Heike Pietge, Saskia Hussung, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|March 17, 2009
Tumor suppressor genes in myeloid differentiation and leukemogenesisChristian Britschgi, Martin F Fey
Swiss Medical Weekly|November 25, 2010
Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation?Mathias Jenal, Christian Britschgi, Martin F Fey, et al.
Radiation Oncology (London, England)|June 2, 2018
Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancerChristian Britschgi, Oliver Riesterer, Irene A Burger, et al.
Oncotarget|April 23, 2016
Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1Kamil Andrzej Lipinski, Christian Britschgi, Karen Schrader, et al.
Molecular Genetics & Genomic Medicine|August 5, 2020
Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene)Reza Asadollahi, Christian Britschgi, Pascal Joset, et al.
International Journal of Molecular Sciences|February 13, 2026
Identification of DMP1 as Novel p53 Repressed Transcriptional TargetJun Xu, Christian Britschgi, Gustav Arvidsson, et al.
JCO Clinical Cancer Informatics|August 25, 2022
MTPpilot: An Interactive Software for Visualization of Next-Generation Sequencing Results in Molecular Tumor BoardsAbdullah Kahraman, Fabian M Arnold, Jacob Hanimann, et al.
Scientific Reports|May 25, 2019
BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assemblyLukas Frischknecht, Christian Britschgi, Patricia Galliker, et al.
Targeted Oncology|September 22, 2022
Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET geneAlessa Fischer, Lorenz Bankel, Stefanie Hiltbrunner, et al.
JCO Precision Oncology|January 7, 2022
Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal CancerDilara Akhoundova, Heike Pietge, Saskia Hussung, et al.
Pageof 5